Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate (Q28362580)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate	scientific article

Statements

scholarly article

0 references

Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate (English)

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R V Goddard

1

0 references

A G Prentice

2

0 references

J A Copplestone

3

0 references

E R Kaminski

4

0 references

language of work or name

0 references

publication date

October 2001

0 references

Clinical and Experimental Immunology

0 references

126

0 references

1

0 references

16-28

0 references

Dendritic cells and the control of immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

20 March 2017

Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Dendritic cell maturation and generation of immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Effects of TGF-beta on the immune system: implications for cancer immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Follow-up evaluation of a phase II prostate cancer vaccine trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Dendritic cell-based vaccine: a promising approach for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Cells and cytokines in immunotherapy and gene therapy of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Dendritic cells: development, function and potential use for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Impediments to successful immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Why are dendritic cells central to cancer immunotherapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Advances in the biology and treatment of B-cell chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

29 September 2017

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

2 June 2018

In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

2 June 2018

Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

2 June 2018

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

2 June 2018

The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

2 June 2018

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

2 June 2018

The biology and clinical applications of dendritic cells.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01617.X

21 January 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01617.X

21 January 2018

Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01617.X

21 January 2018

Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

27 November 2018

Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906182

27 November 2018

Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells require maturation via CD40 to generate protective antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One hundred years of cancer immunotherapy: a critical appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cell immuno-therapy in disseminated parathyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulatory and inhibitory differentiation of human myeloid dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects on human peripheral lymphocytes of in vivo administration of 9-beta-D-arabinofuranosyl-2-fluoroadenine-5'-monophosphate (NSC 312887), a new purine antimetabolite

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of primary peptide-specific CD8+ cytotoxic T-lymphocytes in vitro using allogeneic dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11678895

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2249.2001.01617.X

0 references

release_ey2cjlgo4ncvleogytpza3gy4q

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28362580&oldid=1965449884"